Immune response in ofatumumab treated multiple sclerosis patients after SARS-CoV-2 vaccination

OBJECTIVE: The pandemic induced by SARS-CoV-2 has huge implications for patients with immunosuppression that is caused by disorders or specific treatments. Especially approaches targeting B cells via anti-CD20 therapy are associated with impaired humoral immune response but sustained cellular immuni...

Descripción completa

Detalles Bibliográficos
Autores principales: Faissner, Simon, Heitmann, Neele, Plaza-Sirvent, Carlos, Trendelenburg, Paulina, Ceylan, Ulas, Motte, Jeremias, Bessen, Clara, Urlaub, Doris, Watzl, Carsten, Overheu, Oliver, Reinacher-Schick, Anke, Hellwig, Kerstin, Pfaender, Stephanie, Schmitz, Ingo, Gold, Ralf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471319/
https://www.ncbi.nlm.nih.gov/pubmed/36119053
http://dx.doi.org/10.3389/fimmu.2022.980526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471319/
https://www.ncbi.nlm.nih.gov/pubmed/36119053
http://dx.doi.org/10.3389/fimmu.2022.980526

Ejemplares similares